Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]:
SEC Accession No. 0001104659-20-132516
Filing Date
2020-12-04
Accepted
2020-12-04 17:25:24
Documents
5
Effectiveness Date
2020-12-04

Document Format Files

Seq Description Document Type Size
1 SUPPL tm2037777-1_suppl.htm SUPPL 508559
2 GRAPHIC image_001.jpg GRAPHIC 4164
3 GRAPHIC image_002.jpg GRAPHIC 30519
4 GRAPHIC image_003.jpg GRAPHIC 32395
5 GRAPHIC image_004.jpg GRAPHIC 4167
  Complete submission text file 0001104659-20-132516.txt   608251
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SUPPL | Act: 98 | File No.: 333-239025 | Film No.: 201370733
SIC: 2834 Pharmaceutical Preparations